-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F+tsLxps1fIYmDShhQkQG060Uxld0GkGibFq2D81qmJJQyj+rRPKu9UwR7bMeCcX tCWTSLd2VOCctlWrP4f+EA== 0001181431-05-016426.txt : 20050314 0001181431-05-016426.hdr.sgml : 20050314 20050314144302 ACCESSION NUMBER: 0001181431-05-016426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050310 FILED AS OF DATE: 20050314 DATE AS OF CHANGE: 20050314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COTHERIX INC CENTRAL INDEX KEY: 0001138812 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 5000 SHORELINE COURT STREET 2: SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-808-6500 MAIL ADDRESS: STREET 1: 5000 SHORELINE COURT STREET 2: SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXHALE THERAPEUTICS INC DATE OF NAME CHANGE: 20010503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gray Smith Christine CENTRAL INDEX KEY: 0001293631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50794 FILM NUMBER: 05678104 BUSINESS ADDRESS: BUSINESS PHONE: (650) 808-6500 MAIL ADDRESS: STREET 1: 5000 SHORELINE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd72255.xml GRAY SMITH FORM 4, MARCH 2005 X0202 4 2005-03-10 0 0001138812 COTHERIX INC CTRX 0001293631 Gray Smith Christine 5000 SHORELINE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Executive VP, CFO &Secretary Common Stock 2005-03-10 4 M 0 2970 4.2904 A 6000 D Stock Option (Right to Buy) 4.2904 2005-03-10 4 M 0 2970 0 D 2014-04-04 Common Stock 2970 102682 D Stock Option (Right to Buy) 8.30 2005-03-11 4 A 0 11876 0 A 2015-03-10 Common Stock 11876 11876 D Stock Option (Right to Buy) 8.30 2005-03-11 4 A 0 88124 0 A 2015-03-10 Common Stock 88124 88124 D The option becomes exercisable as to 23,307 option shares on the date of grant and on each January 1st through January 1, 2007. 12,423 option shares shall become exercisable on January 1, 2008. The shares are subject to a repurchase right that lapses over a 4 year period. The two options granted on March 11, 2005 in the aggregate become exercisable for 25% of the option shares upon completion of 12 months of service from the grant date and for the balance of the option shares in 36 equal successive monthly installments thereafter. Dana Melton, as Attorney-in-Fact 2005-03-14 -----END PRIVACY-ENHANCED MESSAGE-----